FDA Inspection 1142728 — Iterum Therapeutics U.S. Ltd.
The FDA completed an inspection of Iterum Therapeutics U.S. Ltd. on April 23, 2021 in Old Saybrook, CT. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 23, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Old Saybrook, CT (United States)
Additional Details
Sponsor, Contract Research Organization